Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.

Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, Cant AJ, Thrasher AJ, Cowan MJ, Albert MH, Small T, Pai SY, Haddad E, Lisa A, Hambleton S, Slatter M, Cavazzana-Calvo M, Mahlaoui N, Picard C, Torgerson TR, Burroughs L, Koliski A, Neto JZ, Porta F, Qasim W, Veys P, Kavanau K, Hönig M, Schulz A, Friedrich W, Notarangelo LD.

Blood. 2011 Aug 11;118(6):1675-84. doi: 10.1182/blood-2010-11-319376. Epub 2011 Jun 9.

2.

Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.

Doğu F, Kurtuluş-Ulküer M, Bilge Y, Bozdoğan G, Ulküer U, Malhatun E, Ikincioğullari A, Babacan E.

Pediatr Transplant. 2006 May;10(3):395-9.

PMID:
16677369
3.

Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.

Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, Mazzolari E, Slatter MA, Le Deist F, Blanche S, Veys P, Fasth A, Bredius R, Sedlacek P, Wulffraat N, Ortega J, Heilmann C, O'Meara A, Wachowiak J, Kalwak K, Matthes-Martin S, Gungor T, Ikinciogullari A, Landais P, Cant AJ, Friedrich W, Fischer A.

Blood. 2008 Jan 1;111(1):439-45. Epub 2007 Sep 27.

4.

Current and emerging treatment options for Wiskott-Aldrich syndrome.

Worth AJ, Thrasher AJ.

Expert Rev Clin Immunol. 2015;11(9):1015-32. doi: 10.1586/1744666X.2015.1062366. Epub 2015 Jul 9. Review.

PMID:
26159751
5.

Outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome.

Shin CR, Kim MO, Li D, Bleesing JJ, Harris R, Mehta P, Jodele S, Jordan MB, Marsh RA, Davies SM, Filipovich AH.

Bone Marrow Transplant. 2012 Nov;47(11):1428-35. doi: 10.1038/bmt.2012.31. Epub 2012 Mar 19.

PMID:
22426750
7.

Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).

Muñoz A, Olivé T, Martinez A, Bureo E, Maldonado MS, Diaz de Heredia C, Sastre A, Gonzalez-Vicent M; Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).

Pediatr Hematol Oncol. 2007 Sep;24(6):393-402.

PMID:
17710656
8.

Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation.

Pai SY, DeMartiis D, Forino C, Cavagnini S, Lanfranchi A, Giliani S, Moratto D, Mazza C, Porta F, Imberti L, Notarangelo LD, Mazzolari E.

Bone Marrow Transplant. 2006 Nov;38(10):671-9. Epub 2006 Oct 2.

PMID:
17013426
9.

Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.

Kobayashi R, Ariga T, Nonoyama S, Kanegane H, Tsuchiya S, Morio T, Yabe H, Nagatoshi Y, Kawa K, Tabuchi K, Tsuchida M, Miyawaki T, Kato S.

Br J Haematol. 2006 Nov;135(3):362-6.

PMID:
17032176
10.

Hematopoietic stem cell transplantation from a donor with Klinefelter syndrome for Wiskott-Aldrich syndrome.

Balci YI, Turul T, Daar G, Anak S, Devecioglu O, Tezcan I, Cetinkaya DU.

Pediatr Transplant. 2008 Aug;12(5):597-9. doi: 10.1111/j.1399-3046.2008.00908.x. Epub 2008 Mar 10.

PMID:
18331539
11.

Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.

Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N.

Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):84-90. doi: 10.1016/j.bbmt.2008.10.007. Review.

12.

[Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].

Wietstruck P MA, Zúñiga C P, Talesnik G E, Méndez R C, Barriga C F.

Rev Med Chil. 2007 Jul;135(7):917-23. Epub 2007 Sep 6. Spanish.

13.

Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.

Friedrich W, Schütz C, Schulz A, Benninghoff U, Hönig M.

Immunol Res. 2009;44(1-3):18-24. doi: 10.1007/s12026-008-8063-8.

PMID:
18846321
14.

Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.

Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ, Casper JT, Cowan MJ, Edwards JR, Fasth A, Gale RP, Junker A, Kamani NR, Loechelt BJ, Pietryga DW, Ringdén O, Vowels M, Hegland J, Williams AV, Klein JP, Sobocinski KA, Rowlings PA, Horowitz MM.

Blood. 2001 Mar 15;97(6):1598-603.

15.

Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.

Hacein-Bey Abina S, Gaspar HB, Blondeau J, Caccavelli L, Charrier S, Buckland K, Picard C, Six E, Himoudi N, Gilmour K, McNicol AM, Hara H, Xu-Bayford J, Rivat C, Touzot F, Mavilio F, Lim A, Treluyer JM, Héritier S, Lefrère F, Magalon J, Pengue-Koyi I, Honnet G, Blanche S, Sherman EA, Male F, Berry C, Malani N, Bushman FD, Fischer A, Thrasher AJ, Galy A, Cavazzana M.

JAMA. 2015 Apr 21;313(15):1550-63. doi: 10.1001/jama.2015.3253.

16.

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley M, Kumar A, Jodele S, Myers KC, Chandra S, Leemhuis T, Mehta PA, Bleesing JJ, Davies SM, Jordan MB, Filipovich AH.

Biol Blood Marrow Transplant. 2013 Nov;19(11):1625-31. doi: 10.1016/j.bbmt.2013.09.001. Epub 2013 Sep 10.

17.
18.

Wiskott-Aldrich syndrome.

Notarangelo LD, Miao CH, Ochs HD.

Curr Opin Hematol. 2008 Jan;15(1):30-6. Review.

PMID:
18043243
19.

Impact of conditioning on outcome of hematopoietic stem cell transplantation for wiskott-Aldrich syndrome.

Stepensky P, Krauss A, Goldstein G, Zaidman I, Elhasid R, Bielorai B, Somech R, Or R, Stein J, Revel-Vilk S, Weintraub M.

J Pediatr Hematol Oncol. 2013 Aug;35(6):e234-8. doi: 10.1097/MPH.0b013e318279cbfc.

PMID:
23389496
20.

Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation.

Mossallam GI, Kamel AM, Storer B, Martin PJ.

Biol Blood Marrow Transplant. 2009 Mar;15(3):352-9. doi: 10.1016/j.bbmt.2008.12.496.

Supplemental Content

Support Center